NCT06307600View on ClinicalTrials.gov

The Safety and Efficacy of RD06-03 CART Cell Injection in Patients With R/R Acute B-lymphoblastic Leukemia

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

March 15, 2024

Primary Completion Date

March 15, 2025

Study Completion Date

April 1, 2027

Conditions
B Lymphoblastic Leukemia/Lymphoma
Interventions
DRUG

RD06-03 cell injection

The patients in this intervention will use RD06-03 cell injection with 3 dose dose 1: 1×10\^5 CAR+ T Cells/kg dose 2: 3×10\^5 CAR+ T Cells/kg dose 3: 5×10\^5 CAR+ T Cells/kg Dosage form: IV injection Frequency of administration：1 time

Trial Locations (2)

230036

RECRUITING

Anhui Provincial Hospital, Hefei

430000

RECRUITING

Union Hospital Tongji Medical College Huazhong University of Science and Technology, Wuhan

All Listed Sponsors
lead

Anhui Provincial Hospital

OTHER_GOV